Absci Corp (ABSI) awards RSUs and stock options to director Szela

Rhea-AI Filing Summary

Absci Corp director Mary T. Szela received new equity awards as part of her compensation. She was granted 8,400 Restricted Stock Units, each representing one share of common stock, and 33,200 stock options with a per-share exercise price of $7.34.

The RSUs and options will vest in full on the earlier of the first anniversary of the grant date or Absci’s next annual stockholder meeting, provided she continues serving the company through that date. After these grants, she directly holds 8,400 RSUs and 33,200 options scheduled to expire on June 3, 2036.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Szela Mary T

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	33,200	$0.00	--
Grant/Award	Common Stock	8,400	$0.00	--

Holdings After Transaction: Stock Option (right to buy) — 33,200 shares (Direct, null); Common Stock — 8,400 shares (Direct, null)

Footnotes (1)

1. The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest and be settled in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. The shares subject to this option vest and become exercisable in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date.

Key Figures

RSU grant: 8,400 shares Stock options granted: 33,200 options Option exercise price: $7.34 per share +3 more

6 metrics

RSU grant 8,400 shares Restricted Stock Units granted to director on June 4, 2026

Stock options granted 33,200 options Stock Option (right to buy) granted on June 4, 2026

Option exercise price $7.34 per share Conversion/exercise price for 33,200 options

RSU holding after grant 8,400 shares Total common stock underlying RSUs following transaction

Option holding after grant 33,200 options Total options held following transaction

Option expiration date June 3, 2036 Expiration date for the 33,200 stock options

Key Terms

Restricted Stock Units ("RSUs"), Absci Corporation 2021 Stock Option and Incentive Plan, Stock Option (right to buy), vest and be settled in full, +1 more

5 terms

Restricted Stock Units ("RSUs") financial

"The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Absci Corporation 2021 Stock Option and Incentive Plan financial

"Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan."

Stock Option (right to buy) financial

"security_title: "Stock Option (right to buy)" with underlying security title Common Stock."

vest and be settled in full financial

"The RSUs shall vest and be settled in full on the earlier of the first anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders."

continuous service financial

"subject to the Reporting Person's continuous service to the Issuer through such date."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Szela Mary T

(Last) (First) (Middle)

C/O ABSCI CORPORATION

18105 SE MILL PLAIN BOULEVARD

(Street)

VANCOUVER WASHINGTON 98683

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Absci Corp [ ABSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
06/08/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/04/2026		A		8,400(1)	A	$0	8,400	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$7.34	06/04/2026		A		33,200		(2)	06/03/2036	Common Stock	33,200	$0	33,200	D

Explanation of Responses:

1. The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest and be settled in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date.

2. The shares subject to this option vest and become exercisable in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date.

Remarks:

This amended Form 4, as originally filed on June 8, 2026, is being filed to correct the amount of stock options and RSUs granted to the Reporting Person. This Form 4 amendment updates both equity awards to reflect 33,200 stock options and 8,400 RSUs originally granted to the Reporting Person on June 4, 2026.

	/s/ Shelby Walker, attorney-in-fact	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did Absci (ABSI) grant to director Mary T. Szela?

Absci granted Mary T. Szela 8,400 Restricted Stock Units and 33,200 stock options. Each RSU equals one share of common stock, while the options allow her to buy shares at a fixed exercise price.

What is the exercise price of Mary T. Szela’s Absci (ABSI) stock options?

The granted stock options have an exercise price of $7.34 per share. This means Szela can buy Absci common stock at $7.34 once the options vest, regardless of the market price at that time.

When do Mary T. Szela’s new Absci (ABSI) RSUs and options vest?

Both the RSUs and stock options vest in full on the earlier of the first anniversary of the grant date or Absci’s next annual stockholder meeting. Vesting is conditioned on Szela’s continuous service through that date.

How many Absci (ABSI) stock options does Mary T. Szela hold after this filing?

Following this grant, Szela holds 33,200 stock options directly. These options relate to Absci common stock and are scheduled to expire on June 3, 2036 if not exercised by then.

Are Mary T. Szela’s Absci (ABSI) awards open-market purchases of stock?

No. The filing shows compensation-related grants: 8,400 RSUs and 33,200 stock options. These are awards from Absci, not open-market purchases, and they vest based on her continued board service.